Friday’s Highlights at Noon: Anthera Pharmaceuticals (ANTH), Halcon Resources (HK), NovaBay Pharma (NBY), Quinstreet (QNST), Omeros Corp (OMER)

By Carrie Williams

So far Friday, May 10, NASDAQ is down -0.41% and the S&P is up 0.05%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Anthera Pharmaceuticals (ANTHResearch Report), Halcon Resources (HKResearch Report), NovaBay Pharma (NBYResearch Report), Quinstreet (QNSTResearch Report) and Omeros Corp (OMERResearch Report).

Anthera Pharmaceuticals is up 23.03% in midday trading to $0.09. Shares opened today at $0.08. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

Halcon Resources is down -20.45% in midday trading to $0.70. Shares opened today at $0.88. The company has a 52-week low of $0.62 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $4.50, marking a 411.36% potential upside from current levels. In a report released today, Roth Capital analyst John M. White downgraded HK to Hold. In the last 30 days, insiders have sold $19 worth of HK shares.

NovaBay Pharma is down -16.97% in midday trading to $0.50. Shares opened today at $0.60. The company has a 52-week low of $0.47 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.25, marking a 108.33% potential upside from current levels. In a report issued on March 29, H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on NBY, with a price target of $1, which implies an upside of 67% from current levels.

See today’s analyst top recommended stocks >>

Quinstreet is up 15.09% in midday trading to $15.56. Shares opened today at $13.52. The company has a 52-week low of $11.83 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $20.00, marking a 47.93% potential upside from current levels. In a report released today, Barrington Research analyst James Goss maintained a Buy rating on QNST, with a price target of $20, which represents a potential upside of 48% from where the stock is currently trading.

See today’s analyst top recommended stocks >>

Omeros Corp is up 13.11% in midday trading to $19.24. Shares opened today at $17.01. The company has a 52-week low of $10.30 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $27.50, marking a 61.67% potential upside from current levels. In a report released today, Maxim Group analyst Jason McCarthy maintained a Buy rating on OMER, with a price target of $32, which represents a potential upside of 88% from where the stock is currently trading. Separately, on March 12, Wedbush’s Liana Moussatos maintained a Hold rating on the stock and has a price target of $17.

Trending Stocks Based on Insider Activity >>